145 related articles for article (PubMed ID: 36217263)
21. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
22. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
23. The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population.
Li N; Zhong D; Chen H; Huang T; Hou P; Zhang Y; Chen F; Wang X; Zhang H
Cancer Manag Res; 2019; 11():4097-4107. PubMed ID: 31190982
[No Abstract] [Full Text] [Related]
24. Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse.
Wang H; Liu L; Yan J; Ma W; Du Y; Zhang T
Front Oncol; 2022; 12():1097816. PubMed ID: 36741689
[TBL] [Abstract][Full Text] [Related]
25. Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.
Mascalchi M; Maddau C; Sali L; Bertelli E; Salvianti F; Zuccherelli S; Matucci M; Borgheresi A; Raspanti C; Lanzetta M; Falchini M; Mazza E; Vella A; Luconi M; Pinzani P; Pazzagli M
J Cancer; 2017; 8(12):2223-2230. PubMed ID: 28819424
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].
Lian H; Ding Z; Yuan D; Ma J; Qin J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866
[TBL] [Abstract][Full Text] [Related]
27. Value of circulating tumor cells in the diagnosis and treatment of solitary pulmonary nodules.
Liu D; Mao Y; Ma H
Ann Transl Med; 2021 Mar; 9(6):501. PubMed ID: 33850898
[TBL] [Abstract][Full Text] [Related]
28. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
Front Oncol; 2022; 12():769203. PubMed ID: 35425708
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity and specificity of folate receptor α-positive circulating tumour cells in gastric cancer.
Cao B; Liu L; Zhang R; Dong H; Shen J
Postgrad Med J; 2024 Jan; 100(1180):112-119. PubMed ID: 37973392
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of recombinant virus-specific detection for viable circulating tumor cells in lung cancer patients].
Xiao Y; Liu S; Wang ZZ; Chen Y; Li J; Li F
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Feb; 42(2):101-105. PubMed ID: 30704181
[No Abstract] [Full Text] [Related]
31. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
[TBL] [Abstract][Full Text] [Related]
32. Identify the Clinicopathological Characteristics of Lung Carcinoma Patients Being False Negative in Folate Receptor Based Circulating Tumor Cell Detection.
Jiang S; Wang H; Zhu J; Xu X; Chen L; Wang B; Zhou B; Zhu Y; Zhang Z; Ma B; Du B; Yang Y
Small Methods; 2023 Sep; 7(9):e2300055. PubMed ID: 37330646
[TBL] [Abstract][Full Text] [Related]
33. Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer.
Wu Q; Zheng H; Gu J; Cheng Y; Qiao B; Wang J; Xiong L; Sun S; Wu Z; Bao A; Tong Y
J Clin Lab Anal; 2022 Jan; 36(1):e24180. PubMed ID: 34919735
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
35. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
[TBL] [Abstract][Full Text] [Related]
36. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
[No Abstract] [Full Text] [Related]
37. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor- Positive circulating tumor cells and HSP90.
Huang M; Cheng L; Mo S; Ru H; Mo X; Yan L
Front Oncol; 2022; 12():912016. PubMed ID: 36203415
[TBL] [Abstract][Full Text] [Related]
38. The value of folate receptor-positive circulating tumour cells as a diagnostic biomarker for lung cancer: a systematic review and meta-analysis.
Chen F; Ni Y; Zhang J; Hao Y; Tian Z; Qiang G
J Int Med Res; 2023 Sep; 51(9):3000605231199763. PubMed ID: 37751487
[TBL] [Abstract][Full Text] [Related]
39. Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.
Wei S; Guo C; He J; Tan Q; Mei J; Yang Z; Liu C; Pu Q; Ma L; Yuan Y; Lin F; Zhu Y; Liao H; Wang W; Liu Z; Li Q; Jiang B; Li C; Xia L; Zhao K; Gan F; Cheng J; Wu Z; Wang Y; Lin Y; Kou Y; Che G; Chen L; Li J; Liu L
JAMA Surg; 2019 Jul; 154(7):e190972. PubMed ID: 31042283
[TBL] [Abstract][Full Text] [Related]
40. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
